Takeda Pharmaceutical Company is a global, research-driven biopharmaceutical firm with a rich history of over 240 years. Founded in 1781 in Osaka, Japan, as a herbal medicine shop, Takeda has grown to become one of the largest pharmaceutical manufacturers worldwide, employing around 49,095 people across 80 countries and regions. The company has evolved significantly since its early days, transitioning from traditional herbal remedies to Western medicines in the 19th century. Takeda established its first pharmaceutical manufacturing facility in 1895 and has since expanded its operations internationally, particularly after World War II. Notable milestones include the formation of TAP Pharmaceuticals in 1985 and the acquisition of Shire plc in 2019, which enhanced its position in the biopharmaceutical sector. Takeda focuses on developing life-transforming treatments across various therapeutic areas, guided by a commitment to integrity and patient care.